Literature DB >> 29789190

Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry to identify MLST clade 4 Clostridium difficile isolates.

Jing-Wei Cheng1, Chang Liu1, Timothy Kudinha2, Meng Xiao3, Shu-Ying Yu1, Chun-Xia Yang4, Ming Wei4, Guo-Wei Liang5, Dong-Hua Shao5, Fanrong Kong6, Zhao-Hui Tong7, Ying-Chun Xu8.   

Abstract

Clostridium difficile is the leading cause of health care-associated infections. Previous studies suggest that C. difficile MLST clade 4 strains with higher drug resistance rates constitute the major clone spreading in China. Thus development of a rapid and accurate typing method for these strains is needed to monitor the epidemiology of this clone and to guide clinical treatment. A total of 160 non-duplicate C. difficile isolates recovered from three large teaching hospitals in Beijing were studied. All the 41 clade 4 C. difficile isolates clustered together on the PCA dendrogram. Spectra peak statistics revealed that five markers (2691.43Da, 2704.91Da, 2711.93Da, 3247.27Da and 3290.76Da) can easily and reliably distinguish between clade 4 and non-clade 4 isolates, with area under the curve (AUC) values of 0.991, 0.997, 0.973, 1 and 1, respectively. In conclusion, MALDI-TOF MS is a very simple and accurate method for identifying C. difficile MLST clade 4 strains.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clade 4; Clostridium difficile; MALDI-TOF MS; MLST; Typing

Mesh:

Year:  2018        PMID: 29789190     DOI: 10.1016/j.diagmicrobio.2018.04.011

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  1 in total

1.  Antibiotic Resistances and Molecular Characteristics of Clostridioides difficile in ICUs in a Teaching Hospital From Central South China.

Authors:  Xiujuan Meng; Xun Huang; Zhong Peng; Yaowang Wang; Sidi Liu; Cui Zeng; Juping Duan; Ximao Wen; Chenchao Fu; Anhua Wu; Chunhui Li
Journal:  Front Med (Lausanne)       Date:  2021-12-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.